4SCAR-T cell therapy (Shenzhen Geno-Immune Medical Institute)
N/A
Report date: 2022/07/20 14:45:09
Base Information
Drug Name4SCAR-T cell therapy (Shenzhen Geno-Immune Medical Institute)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesShenzhen Geno-Immune Medical Institute
China Registration ClassN/A
Develop Information
Active CompaniesShenzhen Geno-Immune Medical Institute
Inactive CompaniesN/A
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A